Acasti Pharma Inc (ACST)
2.96
-0.07
(-2.31%)
USD |
NASDAQ |
May 03, 16:00
2.875
-0.08
(-2.87%)
Pre-Market: 20:00
Acasti Pharma Cash from Operations (Quarterly): -1.892M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.892M |
| September 30, 2023 | -2.113M |
| June 30, 2023 | -6.24M |
| March 31, 2023 | -3.326M |
| December 31, 2022 | -3.722M |
| September 30, 2022 | -3.439M |
| June 30, 2022 | -5.426M |
| March 31, 2022 | -3.145M |
| December 31, 2021 | -4.584M |
| September 30, 2021 | -6.104M |
| June 30, 2021 | -3.401M |
| March 31, 2021 | -1.76M |
| December 31, 2020 | -4.214M |
| September 30, 2020 | -4.176M |
| June 30, 2020 | -4.169M |
| March 31, 2020 | -2.902M |
| December 31, 2019 | -7.107M |
| September 30, 2019 | -6.118M |
| June 30, 2019 | -6.824M |
| March 31, 2019 | -8.527M |
| December 31, 2018 | -6.832M |
| September 30, 2018 | -5.146M |
| June 30, 2018 | -4.281M |
| March 31, 2018 | -3.207M |
| December 31, 2017 | -3.499M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.722M |
| June 30, 2017 | -1.266M |
| November 30, 2016 | -1.284M |
| August 31, 2016 | -0.6901M |
| May 31, 2016 | -1.589M |
| February 29, 2016 | -1.199M |
| November 30, 2015 | -1.195M |
| August 31, 2015 | -1.681M |
| May 31, 2015 | -0.7761M |
| February 28, 2015 | -1.759M |
| November 30, 2014 | -1.838M |
| August 31, 2014 | -1.695M |
| May 31, 2014 | -0.4616M |
| February 28, 2014 | -4.155M |
| November 30, 2013 | -0.8066M |
| August 31, 2013 | -0.2425M |
| May 31, 2013 | -0.9112M |
| February 28, 2013 | 0.1363M |
| November 30, 2012 | -0.5805M |
| August 31, 2012 | -1.414M |
| May 31, 2012 | -0.6319M |
| February 29, 2012 | -1.433M |
| November 30, 2011 | -3.144M |
| August 31, 2011 | -0.6448M |
| May 31, 2011 | -0.4252M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.107M
Minimum
Dec 2019
-1.76M
Maximum
Mar 2021
-4.245M
Average
-4.169M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 14.31M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6196M |
| Xenon Pharmaceuticals Inc | -35.46M |
| ESSA Pharma Inc | -6.787M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.554M |
| Free Cash Flow | -13.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0424 |
| Free Cash Flow Yield | -17.50% |